Showing results (491-500 of 2,455) with videos related to
Sort By:
Pageof 246
Therapie|October 9, 2022
Effects of missed dose and delayed dose quetiapine on its pharmacokinetics and pharmacodynamicsJanthima MethaneethornTherapie|March 7, 2021
[Medication errors reporting in drug clinical trials: Role of the clinical research pharmacist?]Elodie Delavoipière, Chloé Fourage, Margaret Macro, et al.Therapie|January 11, 2022
Epidemiology and economic burden of "serious" adverse drug reactions: Real-world evidence research based on pharmacovigilance dataMarion Tissot, Marie-Blanche Valnet-Rabier, Thomas Stalder, et al.Therapie|February 23, 2021
[Thirty years of nefopam abuse in France]Bruno Revol, Jessica Delorme, Émilie Jouanjus, et al.Therapie|December 13, 2021
From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicityStéphane Ederhy, Perrine Devos, Ariel Cohen, et al.Therapie|October 25, 2022
Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM surveyLéna Blayac, Camille Ponte, Monique Lavaud, et al.Therapie|December 19, 2021
Of some innovations in clinical trial design in hematology and oncologyVincent LévyTherapie|October 25, 2021
Application of benvitimod on psoriasis: A systematic review and meta-analysis of randomized controlled trials. A systematic review of benvitimod on psoriasisLianghong Chen, Yan Wu, Bihuan Xiao, et al.Therapie|April 30, 2019
Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of FranceDamien Driot, Sandrine Ouhayoun, Félix Perinelli, et al.Therapie|May 5, 2019
Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patientsBiswadeep Das, Vikram Singh Rawat, Saravana Kumar Ramasubbu, et al.Pageof 246